CNR1 and obesity disorder: Our results provide a new perspective in the interaction between ghrelin and CB1 receptors and suggest that therapies using new peripheral-restricted CB1 antagonist might be efficacious for the treatment of obesity when ghrelin-inducing food intake signal is overactivated.